Reference Document 2018

The present original French "Document de Référence" of this translated Reference Document was filed with the Autorité des Marchés Financiers on 18 February, 2019, in accordance with Article 212 - 13 of its "règlement général". It may be used in connection with an offering of securities if it is supplemented by a prospectus ("note d'opération") for which the Autorité des Marchés Financiers has issued an endorsement. This Reference Document has been made out by the issuer and engages the responsibility of his signatory.

This Reference Document incorporates by reference the preceding Reference Documents D.18-0041 filed on February 20, 2018 and D.17–0102 filed on 22 February 2017.

The following information is included by reference in the present Reference Document:

  • The year 2017 consolidated financial statements of Sartorius Stedim Biotech prepared using international accounting standards and the report of the statutory auditors relating to these statements, and the Group 2017 management report appearing on pages 114 to 161 and 18 to 78 respectively, of the Reference Document filed with the Autorité des Marchés Financiers on 20 February 2018, under the number D.18-0041.
  • The year 2016 consolidated financial statements of Sartorius Stedim Biotech prepared using international accounting standards and the report of the statutory auditors relating to these statements, and the Group 2016 management report appearing on pages 113 to 160 and 18 to 63 respectively, of the Reference Document filed with the Autorité des Marchés Financiers on 22 February 2017, under the number D.17 - 0102.

The sections of these documents not included are not of interest to an investor, and are covered in another part of this Reference Document.

Copies of the present Reference Document can be obtained from the following: